Cambridge Healthtech Institute’s 7th Annual

3D Cellular Models

Engineering and Applying Predictive Preclinical Screening Models

September 28-29, 2021

 

Biological, toxicological, and pharmacological research has necessitated the way investigators select the most appropriate preclinical screening model. These choices abound for drug screenings and toxicology studies including multicellular 3D biological models, the so-called "-oids" (ie spheroids, tumoroids, organoids), co-culture systems, 3D printing, microfluidic devices, and microphysiological systems (ie organ-on-a-chip, system-on-a-chip, body-on-a-chip). What preclinical model best predicts clinical outcome? Cambridge Healthtech Institute's 7th Annual 3D Cellular Models conference explores the next generation of models as well as strategies to overcome common bottlenecks including standardization, scaling and workflow integration.

 

Who should attend: R&D Pharmaceutical Scientists including Cell Biologists, Tissue Engineers, Assay Developers, Screening Managers and Drug Developers

 

Coverage will include, but is not limited to:

 

3D Cellular and in vivo Modeling

  • Development of high-throughput screening (HTS) for “oids” (spheroids, tumoroids, organoids) in a cost-effective manner across different therapeutic areas
  • Co-Culturing Systems
  • Merging in vitro, in vivo and in silico methods
  • Assay Development for 3D models

     

    Stem Cell-Based Models

  • Establishing induced pluripotent stem cell (iPSC) models to provide a predictive assessment of drug-induced toxicity
  • Case studies on patient-derived iPSC for preclinical drug assessment
  • Patient-on-a-chip system
  • Infrastructure/automation for drug discovery
  • Synthetic and defined extracellular matrices for advanced cellular models
  • Genome editing to generate advanced and phenotypically accurate human cellular disease models

     

    Bioengineered Models

  • Case studies on development and validation on bioengineering techniques such as (but not limited to) organ-on-a-chip, system-on-a-chip, body-on-a-chip
  • Bioprinting
  • Creating more complex micro-environments
  • Incorporating smart biomaterial matrices to provide monitoring tools

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is March 29, 2021.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:

Mary Ann Brown

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781-972-5497

Email: mabrown@healthtech.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286

Email: reymael@healthtech.com


Submit a Speaker Proposal